Abstract
Population aging will likely lead to increases in health care spending and the ability of governments to support entitlement programs such as Medicare and Medicaid. Dementia is a chronic condition that is especially pertinent because of its strong association with old age and because care for dementia is labor intensive and expensive. Indeed, prior research has found that if current dementia prevalence rates persist, population aging will generate very large increases in health care spending for dementia. In this study we considered two alternative assumptions or scenarios about future prevalence. The first adjusts the prevalence projections using recent research that suggests dementia prevalence may be declining. The second uses growth hypertension, obesity and diabetes, and the relationship between dementia and these conditions to adjust future prevalence rates. We find under the first scenario that if the rates of decline in age-specific dementia rates persist, future costs will be much less than previous estimates, about 40 % lower. Under the second scenario, the growth in those conditions makes only small differences in costs.
Similar content being viewed by others
References
Barnes, D. E., & Yaffe, K. (2011). The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurology, 10(9), 819–828.
Chan, K. Y., Wang, W., Wu, J. J., Liu, L., Theodoratou, E., Car, J., et al. (2013). Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990–2010: a systematic review and analysis. Lancet, 381(9882), 2016–2023.
Hurd, M., Martorell, F., Delavande, A., Mullen, K., & Langa, K. M. (2013). The monetary costs of dementia in the United States. New England Journal of Medicine, 368(14), 1326–1334.
Jorm, A. F. (1994). A short form of the informant questionnaire on cognitive decline in the elderly (IQCODE): development and cross-validation. Psychological Medicine, 24, 145–53 [Erratum, Psychol Med 1995;25:437.].
Langa, K. M., Larson, E. B., Karlawish, J. H., et al. (2008). Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers & Dementia, 4, 134–144.
Larson, E. B., Yaffe, K., & Langa, K. M. (2013). New insights into the dementia epidemic. New England Journal of Medicine, 369(24), 2275–2277.
Manton, K. C., Gu, X. L., & Ukraintseva, S. V. (2005). Declining prevalence of dementia in the U.S. elderly population. Advances in Gerontology, 16, 30–37.
Matthews, F., Arthur, A., Barnes, L. E., Bond, J., et al. (2013). Lancet, 382, 1405–12.
Plassman, B. L., et al. (2007). Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology, 29(1–2), 125–132.
Plassman, B. L., et al. (2008). Prevalence of cognitive impairment without dementia in the United States. Annals of Internal Medicine, 148(6), 427–434.
Prince, M., Guerchet, M., & Prina, M. (2013). Alzheimer’s disease international. Policy brief for heads of government: The global impact of dementia 2013–2050. London: Alzheimer’s Disease International.
Rocca, W. A., Petersen, R. C., Knopman, D. S., Hebert, L. E., Evans, D. A., Hall, K. S., et al. (2011). Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States. Alzheimers Dement, 7(1), 80–93.
Schrijvers, E. M. C., Verhaaren, B. F. J., Koudstaal, P. J., Hofman, A., Ikram, M. A., & Breteler, M. B. B. (2012). Is dementia incidence declining? trends in dementia incidence since 1990 in the Rotterdam Study. Neurology, 78(19), 1456–1463.
Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurology, 11(11), 1006–1012.
Wilson, R., Weir, D., Leurgans, S., Evans, D., Hebert, L., Langa, K. M., Plassman, B., Small, B., & Bennett, D. (2011). Sources of variability in estimates of the prevalence of Alzheimer’s disease in the United States. Alzheimer’s and Dementia, 7(1), 74–79.
Wimo, A., Jönsson, L., Bond, J., Prince, M., & Winblad, B. (2013). Alzheimer disease international. the worldwide economic impact of dementia 2010. Alzheimers & Dementia, 9(1), 1–11.
Wu, Y. T., Lee, H. Y., Norton, S., Chen, C., Chen, H., He, C., et al. (2013). Prevalence studies of dementia in mainland china, Hong Kong and Taiwan: a systematic review and meta-analysis. PLoS One, 8(6), e66252.
Acknowledgments
Research support from the National Institute on Aging under grants R01AG030155 and R01AG041116 is gratefully acknowledged
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hurd, M.D., Martorell, P. & Langa, K. Future Monetary Costs of Dementia in the United States Under Alternative Dementia Prevalence Scenarios. Population Ageing 8, 101–112 (2015). https://doi.org/10.1007/s12062-015-9112-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12062-015-9112-4